Article Versions Notes

Pető Á, Kósa D, Fehér P, Ujhelyi Z, Sinka D, Vecsernyés M, Szilvássy Z, Juhász B, Csanádi Z, Vígh L, et al. Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome. Molecules. 2020; 25(2):429. https://doi.org/10.3390/molecules25020429

Pető, Ágota, Dóra Kósa, Pálma Fehér, Zoltán Ujhelyi, Dávid Sinka, Miklós Vecsernyés, Zoltán Szilvássy, Béla Juhász, Zoltán Csanádi, László Vígh, and et al. 2020. "Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome" Molecules 25, no. 2: 429. https://doi.org/10.3390/molecules25020429

Pető, Á., Kósa, D., Fehér, P., Ujhelyi, Z., Sinka, D., Vecsernyés, M., Szilvássy, Z., Juhász, B., Csanádi, Z., Vígh, L., & Bácskay, I. (2020). Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome. Molecules, 25(2), 429. https://doi.org/10.3390/molecules25020429